BLUE 400
Enables precise definition of tumor margins during the removal of malignant brain tumor tissue. This is indispensable to preserve vital and functional areas of the brain and to ensure that the patient’s quality of life is not impaired. BLUE 400 serves as an excellent aid for visualizing tumors clearly at any time during the procedure. BLUE 400 enables precise definition of tumor margins during the removal of malignant brain tumor tissue. This is indispensable to preserve vital and functional areas of the brain and to ensure that the patient’s quality of life is not impaired. BLUE 400 serves as an excellent aid for visualizing tumors clearly at anytime during the procedure.
Workflow Unchanged.
BLUE 400 was developed by Carl Zeiss in close cooperation with leading neurosurgeons. BLUE 400 is a highly integrated procedure supporting the intuitive performance of fluorescence-guided tumor resection.
In a blink of an eye, the surgeon can switch between the xenon white light view and the BLUE 400 mode visualizing tumor margins clearly and instantly. Any time during the operation the workflow remains unchanged.
Please note: the drug 5ALA is not available in the United States and the FDA requires an "Investigational New Drug Application".
